 Home > Medical News > Latest Medical News > Jingfeng Pharmaceutical Letrozole Tablets Obtained Drug Registration Approval

Jingfeng Pharmaceutical Letrozole Tablets Obtained Drug Registration Approval

 Last Update: 2021-06-22
 Source: Internet
 Author: User

Tags

opdivo drug

pdr drug reference

pravastatin drug class

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On June 10, Jingfeng Pharmaceutical issued an announcement stating that its subsidiary Hainan Jinrui Pharmaceutical had obtained the "Drug Registration Approval Document" for the chemical drug "Letrozole Tablets" approved and issued by the State Drug Administration
.

It is reported that letrozole is a selective, non-steroidal aromatase inhibitor, which has no negative effects on the secretion of glucocorticoids and mineralocorticoids and thyroid function
.
It can competitively bind to the heme of the cytochrome P450 enzyme subunit, thereby inhibiting aromatase, leading to a decrease in the biosynthesis of estrogen in all tissues

The drug is mainly used for adjuvant treatment of patients with early postmenopausal breast cancer who have received tamoxifen for 5 years, or adjuvant treatment for patients with early postmenopausal breast cancer who are positive for estrogen or progesterone receptors
.
It is also suitable for the treatment of postmenopausal, estrogen receptor-positive, progesterone-receptor-positive, or advanced breast cancer patients whose receptor status is unknown.

These patients have natural menopause or artificially induced menopause

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.